AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Stress and Brain Article
PDF (1.1 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

The Role of Stress in the Progression of Motor Neuron Disease: Mechanisms and Implications for Treatment

Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou 215006, China
Institute of Neuroscience, Soochow University, Suzhou 215123, China
Jiangsu Key Laboratory of Neuropsychiatric Diseases, Soochow University, Suzhou 215123, Jiangsu, China
Show Author Information

Abstract

Motor neuron diseases (MND) are a group of rare neurodegenerative diseases that significantly affect the survival of patients. The disease progresses rapidly, and currently, there is no cure for MND. Therefore, delays in MND progression and improvements in the patient’s quality of life have become crucial aspects of clinical work. Stress—a response to environmental or psychological changes—significantly affects body metabolism. In particular, excessive stress can harm the human body. Here, we review recent literature exploring the impact of stress on the progression of MND. This review also discusses the potential mechanisms of stress-induced MND deterioration, including activation of the hypothalamic–pituitary–adrenal axis, abnormal microglial activation, oxidative stress, and the accumulation of stress granules. The role of stress in the pathological changes of MND and the importance of stress management in the treatment of MND have been emphasized. Here, we highlight that the attention of clinicians to this crucial aspect can significantly influence the course and outcome of the disease.

Keywords

environmental factorsstressMNDHPAmicrogliaoxidative stress

References

[1]
Dharmadasa, T., Matamala, J. M., Huynh, W., Zoing, M. C., Kiernan, M. C. Motor neurone disease. Handbook of Clinical Neurology, 2018, 159: 345–357.
Crossref Google Scholar
[2]
Foster, L. A., Salajegheh, M. K. Motor neuron disease: Pathophysiology, diagnosis, and management. Am J Med, 2019, 132(1): 32–37.
Crossref Google Scholar
[3]
Wang, M. D., Little, J., Gomes, J., Cashman, N. R., Krewski, D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology, 2017, 61: 101–130.
Crossref Google Scholar
[4]
Al-Chalabi, A., Hardiman, O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat Rev Neurol, 2013, 9(11): 617–628.
Crossref Google Scholar
[5]
Szczygielski, J., Mautes, A., Steudel, W. I., Falkai, P., Bayer, T. A., Wirths, O. Traumatic brain injury: Cause or risk of Alzheimer’s disease? A review of experimental studies. J Neural Transm, 2005, 112(11): 1547–1564.
Crossref Google Scholar
[6]
Goldman, S. M., Tanner, C. M., Oakes, D., Bhudhikanok, G. S., Gupta, A., Langston, J. W. Head injury and Parkinson’s disease risk in twins. Annals of Neurology, 2006, 60(1): 65–72.
Crossref Google Scholar
[7]
Chen, H., Richard, M., Sandler, D. P., Umbach, D. M., Kamel, F. Head injury and amyotrophic lateral sclerosis. American Journal of Epidemiology, 2007, 166(7): 810–816.
Crossref Google Scholar
[8]
Kyrou, I., Tsigos, C. Stress hormones: Physiological stress and regulation of metabolism. Current Opinion in Pharmacology, 2009, 9(6): 787–793.
Crossref Google Scholar
[9]
Chrousos, G. P., Gold, P. W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA, 1992, 267(9): 1244–1252.
Crossref Google Scholar
[10]
Yaribeygi, H., Panahi, Y., Sahraei, H., Johnston, T. P., Sahebkar, A. The impact of stress on body function: A review. EXCLI Journal, 2017, 16: 1057–1072.
Google Scholar
[11]
Leonard, B. E. The concept of depression as a dysfunction of the immune system. Current Immunology Reviews, 2010, 6(3): 205–212.
Crossref Google Scholar
[12]
Liu, Y. Z., Wang, Y. X., Jiang, C. L. Inflammation: The common pathway of stress-related diseases. Frontiers in Human Neuroscience, 2017, 11: 316.
Crossref Google Scholar
[13]
Hardiman, O. Global burden of motor neuron diseases: Mind the gaps. The Lancet Neurology, 2018, 17(12): 1030–1031.
Crossref Google Scholar
[14]
Chancellor, A. M., Warlow, C. P. Adult onset motor neuron disease: Worldwide mortality, incidence and distribution since 1950. Journal of Neurology, Neurosurgery & Psychiatry, 1992, 55(12): 1106–1115.
Crossref Google Scholar
[15]
Bäumer, D., Talbot, K., Turner, M. R. Advances in motor neurone disease. J R Soc Med, 2014, 107(1): 14–21.
Crossref Google Scholar
[16]
Alonso, A., Logroscino, G., Jick, S. S., Hernán, M. A. Incidence and lifetime risk of motor neuron disease in the United Kingdom: A population-based study. Eur J Neurol, 2009, 16(6): 745–751.
Crossref Google Scholar
[17]
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., White, L. A. Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature. Neuroepidemiology, 2013, 41(2): 118–130.
Crossref Google Scholar
[18]
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362(6415): 59–62.
Crossref Google Scholar
[19]
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 2011, 72(2): 245–256.
Crossref Google Scholar
[20]
Alan, E., Renton, A. hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 2011, 72(2): 257–268.
Google Scholar
[21]
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 2008, 319(5870): 1668–1672.
Crossref Google Scholar
[22]
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J. P., Lacomblez, L., Pochigaeva, K., Salachas, F. et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet, 2008, 40(5): 572–574.
Crossref Google Scholar
[23]
Kwiatkowski, T. J. Jr, Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 2009, 323(5918): 1205–1208.
Crossref Google Scholar
[24]
Taylor, J. P., Brown, R. H. Jr, Cleveland, D. W. Decoding ALS: From genes to mechanism. Nature, 2016, 539(7628): 197–206.
Crossref Google Scholar
[25]
Chiò, A., Benzi, G., Dossena, M., Mutani, R., Mora, G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 2005, 128(3): 472–476.
Crossref Google Scholar
[26]
Lehman, E. J., Hein, M. J., Baron, S. L., Gersic, C. M. Neurodegenerative causes of death among retired National Football League players. Neurology, 2012, 79(19): 1970–1974.
Crossref Google Scholar
[27]
Russell, E. R., Mackay, D. F., Lyall, D., Stewart, K., MacLean, J. A., Robson, J., Pell, J. P., Stewart, W. Neurodegenerative disease risk among former international rugby union players. J Neurol Neurosurg Psychiatry, 2022, 93(12): 1262–1268.
Crossref Google Scholar
[28]
Gu, D. Q., Ou, S., Tang, M. S., Yin, Z. Y., Wang, Z. G., Liu, G. D. Trauma and amyotrophic lateral sclerosis: A systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2021, 22(3–4): 170–185.
Crossref Google Scholar
[29]
Liu, G. D., Ou, S., Cui, H. J., Li, X., Yin, Z. Y., Gu, D. Q., Wang, Z. G. Head injury and amyotrophic lateral sclerosis: A meta-analysis. Neuroepidemiology, 2021, 55(1): 11–19.
Crossref Google Scholar
[30]
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., Zoing, M. C. Amyotrophic lateral sclerosis. The Lancet, 2011, 377(9769): 942–955.
Crossref Google Scholar
[31]
Blokhuis, A. M., Groen, E. J., Koppers, M., van den Berg, L. H., Pasterkamp, R. J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathologica, 2013, 125(6): 777–794.
Crossref Google Scholar
[32]
Turner, M. R., Bowser, R., Bruijn, L., Dupuis, L., Ludolph, A., McGrath, M., Manfredi, G., Maragakis, N., Miller, R. G., Pullman, S. L. et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013, 14(sup1): 19–32.
Crossref Google Scholar
[33]
Bäumer, D., Ansorge, O., Almeida, M., Talbot, K. The role of RNA processing in the pathogenesis of motor neuron degeneration. Expert Reviews in Molecular Medicine, 2010, 12: e21.
Crossref Google Scholar
[34]
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S. C., Sun, E., Wancewicz, E., Mazur, C. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature Neuroscience, 2011, 14(4): 459–468.
Crossref Google Scholar
[35]
Turner, M. R., Goldacre, R., Ramagopalan, S., Talbot, K., Goldacre, M. J. Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study. Neurology, 2013, 81(14): 1222–1225.
Crossref Google Scholar
[36]
Goh, X. X., Tang, P. Y., Tee, S. F. 8-hydroxy-2’-deoxyguanosine and reactive oxygen species as biomarkers of oxidative stress in mental illnesses: A meta-analysis. Psychiatry Investigation, 2021, 18(7): 603–618.
Crossref Google Scholar
[37]
Weera, M. Biobehavioral interactions between stress and alcohol. Alcohol Research: Current Reviews, 2019, 40(1), arcr.v40.1.04.
Crossref Google Scholar
[38]
Carnevale, R., Sciarretta, S., Violi, F., Nocella, C., Loffredo, L., Perri, L., Peruzzi, M., Marullo, A. G. M., De Falco, E., Chimenti, I. et al. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest, 2016, 150(3): 606–612.
Crossref Google Scholar
[39]
Westeneng, H. J., van Veenhuijzen, K., van der Spek, R. A., Peters, S., Visser, A. E., van Rheenen, W., Veldink, J. H., van den Berg, L. H. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: A longitudinal, population-based, case-control study. The Lancet Neurology, 2021, 20(5): 373–384.
Crossref Google Scholar
[40]
Anderson, E. N., Gochenaur, L., Singh, A., Grant, R., Patel, K., Watkins, S., Wu, J. Y., Pandey, U. B. Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models. Human Molecular Genetics, 2018, 27(8): 1366–1381.
Crossref Google Scholar
[41]
Chen, G. X., Douwes, J., den Berg, L. H., Glass, B., McLean, D., ’t Mannetje, A. M. Sports and trauma as risk factors for Motor Neurone Disease: New Zealand case–control study. Acta Neurologica Scandinavica, 2022, 145(6): 770–785.
Crossref Google Scholar
[42]
Averill, A. J., Kasarskis, E. J., Segerstrom, S. C. Expressive disclosure to improve well-being in patients with amyotrophic lateral sclerosis: A randomised, controlled trial. Psychology & Health, 2013, 28(6): 701–713.
Crossref Google Scholar
[43]
Marconi, A., Gragnano, G., Lunetta, C., Gatto, R., Fabiani, V., Tagliaferri, A., Rossi, G., Sansone, V., Pagnini, F. The experience of meditation for people with amyotrophic lateral sclerosis and their caregivers - a qualitative analysis. Psychology, Health & Medicine, 2016, 21(6): 762–768.
Crossref Google Scholar
[44]
Bongioanni, P., Del Carratore, R., Corbianco, S., Diana, A., Cavallini, G., Masciandaro, S. M., Dini, M., Buizza, R. Climate change and neurodegenerative diseases. Environmental Research, 2021, 201: 111511.
Crossref Google Scholar
[45]
Smith, S. M., Vale, W. W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues in Clinical Neuroscience, 2006, 8(4): 383–395.
Crossref Google Scholar
[46]
Madalena, K. M., Lerch, J. K. The effect of glucocorticoid and glucocorticoid receptor interactions on brain, spinal cord, and glial cell plasticity. Neural Plasticity, 2017, 2017: 8640970.
Crossref Google Scholar
[47]
Myers, B., McKlveen, J. M., Herman, J. P. Glucocorticoid actions on synapses, circuits, and behavior: Implications for the energetics of stress. Frontiers in Neuroendocrinology, 2014, 35(2): 180–196.
Crossref Google Scholar
[48]
Nicolaides, N. C., Kyratzi, E., Lamprokostopoulou, A., Chrousos, G. P., Charmandari, E. Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation, 2015, 22(1–2): 6–19.
Crossref Google Scholar
[49]
O'Connor, D. B., Green, J. A., Ferguson, E., O'Carroll, R. E., O'Connor, R. C. Cortisol reactivity and suicidal behavior: Investigating the role of hypothalamic-pituitary-adrenal axis responses to stress in suicide attempters and ideators. Psychoneuroendocrinology, 2017, 75: 183–191.
Crossref Google Scholar
[50]
Vyas, S., Rodrigues, A. J., Silva, J. M., Tronche, F., Almeida, O. F., Sousa, N., Sotiropoulos, I. Chronic stress and glucocorticoids: From neuronal plasticity to neurodegeneration. Neural Plasticity, 2016, 2016: 6391686.
Crossref Google Scholar
[51]
Bisht, K., Sharma, K., Tremblay, M. È. Chronic stress as a risk factor for Alzheimer’s disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiology of Stress, 2018, 9: 9–21.
Crossref Google Scholar
[52]
Frick, L. R., Williams, K., Pittenger, C. Microglial dysregulation in psychiatric disease. Clinical & Developmental Immunology, 2013, 2013: 608654.
Crossref Google Scholar
[53]
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H. G., Bogerts, B. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res, 2008, 42(2): 151–157.
Crossref Google Scholar
[54]
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., Quevedo, J. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience, 2015, 300: 141–154.
Crossref Google Scholar
[55]
Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., Takebayashi, K., Yoshihara, Y., Omata, K., Matsumoto, K., Tsuchiya, K. J. et al. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry, 2013, 70(1): 49–58.
Crossref Google Scholar
[56]
Minagawa, K., Yamada, S. I., Suzuki, A., Ta, S., Kumai, T., Lambein, F., Kusama-Eguchi, K. Stress-related over-enhancement of the hypothalamic-pituitary-adrenal axis causes experimental neurolathyrism in rats. Environmental Toxicology and Pharmacology, 2019, 72: 103245.
Crossref Google Scholar
[57]
Dong, H. X., Csernansky, J. G. Effects of stress and stress hormones on amyloid-beta protein and plaque deposition. J Alzheimers Dis, 2009, 18(2): 459–469.
Crossref Google Scholar
[58]
Ferri, L., Ajdinaj, P., Rispoli, M. G., Carrarini, C., Barbone, F., D’Ardes, D., Capasso, M., Muzio, A. D., Cipollone, F., Onofrj, M. et al. Diabetes mellitus and amyotrophic lateral sclerosis: A systematic review. Biomolecules, 2021, 11(6): 867.
Crossref Google Scholar
[59]
Jawaid, A., Salamone, A. R., Strutt, A. M., Murthy, S. B., Wheaton, M., McDowell, E. J., Simpson, E., Appel, S. H., York, M. K., Schulz, P. E. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol, 2010, 17(5): 733–739.
Crossref Google Scholar
[60]
Kioumourtzoglou, M. A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., Weisskopf, M. G. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis. JAMA Neurology, 2015, 72(8): 905.
Crossref Google Scholar
[61]
Mariosa, D., Kamel, F., Bellocco, R., Ronnevi L-, O., Almqvist, C., Larsson, H., Ye, W., Fang, F. Antidiabetics, statins and the risk of amyotrophic lateral sclerosis. Eur J Neurol, 2020, 27(6): 1010–1016.
Crossref Google Scholar
[62]
Zhang, L. J., Chen, L., Fan, D. S. The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: A center-based survey in China. Amyotroph Lateral Scler Frontotemporal Degener, 2020, 21(3–4): 209–215.
Crossref Google Scholar
[63]
Tsai, C. P., Lee, J. K. W., Lee, C. T. C. Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis. J Neurol, 2019, 266(9): 2233–2243.
Crossref Google Scholar
[64]
Mariosa, D., Kamel, F., Bellocco, R., Ye, W., Fang, F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol, 2015, 22(11): 1436–1442.
Crossref Google Scholar
[65]
Sun, Y., Lu, C. J., Chen, R. C., Hou, W. H., Li, C. Y. Risk of amyotrophic lateral sclerosis in patients with diabetes: A nationwide population-based cohort study. J Epidemiol, 2015, 25(6): 445–451.
Crossref Google Scholar
[66]
Zeng, P., Wang, T., Zheng, J. N., Zhou, X. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: New evidence from Mendelian randomization using GWAS summary statistics. BMC Medicine, 2019, 17(1): 225.
Crossref Google Scholar
[67]
Logroscino, G. Are diabetes and amyotrophic lateral sclerosis related? Nat Rev Neurol, 2015, 11(9): 488–490.
Crossref Google Scholar
[68]
Beers, D. R., Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. The Lancet Neurology, 2019, 18(2): 211–220.
Crossref Google Scholar
[69]
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., Fleshner, M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience, 2005, 135(4): 1295–1307.
Crossref Google Scholar
[70]
Dahan, S. N., Bragazzi, N. L., Yogev, A., Bar-Gad, M., Barak, V., Amital, H., Amital, D. The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia. Psychiatry Research, 2018, 268: 467–472.
Crossref Google Scholar
[71]
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., Kivimäki, M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain, Behavior, and Immunity, 2015, 49: 206–215.
Crossref Google Scholar
[72]
Black, C., Miller, B. J. Meta-analysis of cytokines and chemokines in suicidality: Distinguishing suicidal versus nonsuicidal patients. Biological Psychiatry, 2015, 78(1): 28–37.
Crossref Google Scholar
[73]
Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P. V., Kapczinski, F., Kauer-Sant'Anna, M. Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression. The Lancet Psychiatry, 2015, 2(11): 1002–1012.
Crossref Google Scholar
[74]
AL-Ayadhi, L. Y., Mostafa, G. A. Elevated serum levels of interleukin-17A in children with autism. J Neuroinflammation, 2012, 9(1): 1–6.
Crossref Google Scholar
[75]
Weber, M. D., Frank, M. G., Tracey, K. J., Watkins, L. R., Maier, S. F. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: A priming stimulus of microglia and the NLRP3 inflammasome. J Neurosci, 2015, 35(1): 316–324.
Crossref Google Scholar
[76]
Fleshner, M., Crane, C. R. Exosomes, DAMPs and miRNA: Features of stress physiology and immune homeostasis. Trends in Immunology, 2017, 38(10): 768–776.
Crossref Google Scholar
[77]
Bogie, J. F. J., Stinissen, P., Hendriks, J. J. A. Macrophage subsets and microglia in multiple sclerosis. Acta Neuropathologica, 2014, 128(2): 191–213.
Crossref Google Scholar
[78]
Kaufmann, F. N., Costa, A. P., Ghisleni, G., Diaz, A. P., Rodrigues, A. L. S., Peluffo, H., Kaster, M. P. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings. Brain, Behavior, and Immunity, 2017, 64: 367–383.
Crossref Google Scholar
[79]
Wohleb, E. S., Delpech, J. C. Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences. Prog Neuropsychopharmacol Biol Psychiatry, 2017, 79: 40–48.
Crossref Google Scholar
[80]
Zhao, W. H., Beers, D. R., Hooten, K. G., Sieglaff, D. H., Zhang, A. J., Kalyana-Sundaram, S., Traini, C. M., Halsey, W. S., Hughes, A. M., Sathe, G. M. et al. Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes. JAMA Neurology, 2017, 74(6): 677.
Crossref Google Scholar
[81]
Frakes, A., Ferraiuolo, L., Haidet-Phillips, A., Schmelzer, L., Braun, L., Miranda, C., Ladner, K., Bevan, A., Foust, K., Godbout, J. et al. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis. Neuron, 2014, 81(5): 1009–1023.
Crossref Google Scholar
[82]
Protter, D. S. W., Parker, R. Principles and properties of stress granules. Trends in Cell Biology, 2016, 26(9): 668–679.
Crossref Google Scholar
[83]
Kedersha, N., Ivanov, P., Anderson, P. Stress Granules and cell signaling: More than just a passing phase? Trends in Biochemical Sciences, 2013, 38(10): 494–506.
Crossref Google Scholar
[84]
Grimaldi, G., Catara, G., Palazzo, L., Corteggio, A., Valente, C., Corda, D. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders. Biochemical Pharmacology, 2019, 167: 64–75.
Crossref Google Scholar
[85]
Catara, G., Grimaldi, G., Schembri, L., Spano, D., Turacchio, G., Lo Monte, M., Beccari, A. R., Valente, C., Corda, D. PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions. Sci Rep, 2017, 7: 14035.
Crossref Google Scholar
[86]
Arimoto, K., Fukuda, H., Imajoh-Ohmi, S., Saito, H., Takekawa, M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol, 2008, 10(11): 1324–1332.
Crossref Google Scholar
[87]
Takahara, T., Maeda, T. Transient sequestration of TORC1 into stress granules during heat stress. Molecular Cell, 2012, 47(2): 242–252.
Crossref Google Scholar
[88]
Wang, J. H., Gan, Y. X., Cao, J., Dong, X. F., Ouyang, W. Pathophysiology of stress granules: An emerging link to diseases (Review). Int J Mol Med, 2022, 49(4): 44.
Crossref Google Scholar
[89]
Hofmann, S., Kedersha, N., Anderson, P., Ivanov, P. Molecular mechanisms of stress granule assembly and disassembly. Biochim Biophys Acta Mol Cell Res, 2021, 1868(1): 118876.
Crossref Google Scholar
[90]
Shin, Y., Brangwynne, C. P. Liquid phase condensation in cell physiology and disease. Science, 2017, 357(6357): eaaf4382.
Crossref Google Scholar
[91]
Matsuki, H., Takahashi, M., Higuchi, M., Makokha, G. N., Oie, M., Fujii, M. Both G3BP1 and G3BP2 contribute to stress granule formation. Genes to Cells, 2013, 18(2): 135–146.
Crossref Google Scholar
[92]
Yang, P. G., Mathieu, C., Kolaitis, R. M., Zhang, P. P., Messing, J., Yurtsever, U., Yang, Z. M., Wu, J. J., Li, Y. X., Pan, Q. F. et al. G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell, 2020, 181(2): 325–345.e28.
Crossref Google Scholar
[93]
Guillén-Boixet, J., Kopach, A., Holehouse, A. S., Wittmann, S., Jahnel, M., Schlüßler, R., Kim, K., Trussina, I. R. E. A., Wang, J., Mateju, D. et al. RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation. Cell, 2020, 181(2): 346–361.e17.
Crossref Google Scholar
[94]
Panas, M. D., Kedersha, N., Schulte, T., Branca, R. M., Ivanov, P., Anderson, P. Phosphorylation of G3BP1-S149 does not influence stress granule assembly. The J Cell Biol, 2019, 218(7): 2425–2432.
Crossref Google Scholar
[95]
Gwon, Y., Maxwell, B. A., Kolaitis, R. M., Zhang, P. P., Kim, H. J., Taylor, J. P. Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner. Science, 2021, 372(6549): eabf6548.
Crossref Google Scholar
[96]
Youn, J. Y., Dunham, W. H., Hong, S. J., Knight, J. D. R., Bashkurov, M., Chen, G. I., Bagci, H., Rathod, B., MacLeod, G., Eng, S. W. M. et al. High-density proximity mapping reveals the subcellular organization of mRNA-associated granules and bodies. Molecular Cell, 2018, 69(3): 517–532.e11.
Crossref Google Scholar
[97]
Cirillo, L., Cieren, A., Barbieri, S., Khong, A., Schwager, F., Parker, R., Gotta, M. UBAP2L forms distinct cores that act in nucleating stress granules upstream of G3BP1. Current Biology, 2020, 30(4): 698–707.e6.
Crossref Google Scholar
[98]
Huang, C. Y., Chen, Y., Dai, H. Q., Zhang, H., Xie, M. Y., Zhang, H. B., Chen, F. L., Kang, X. J., Bai, X. C., Chen, Z. G. UBAP2L arginine methylation by PRMT1 modulates stress granule assembly. Cell Death & Differentiation, 2020, 27(1): 227–241.
Crossref Google Scholar
[99]
Zhang, P. P., Fan, B. C., Yang, P. G., Temirov, J., Messing, J., Kim, H. J., Taylor, J. P. Chronic optogenetic induction of stress granules is cytotoxic and reveals the evolution of ALS-FTD pathology. eLife, 2019, 8: e39578.
Crossref Google Scholar
[100]
Baron, D. M., Kaushansky, L. J., Ward, C. L., Sama, R. R., Chian, Boggio, K. J., Quaresma, A. J., Nickerson, J. A., Bosco, D. A. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics. Molecular Neurodegeneration, 2013, 8: 30.
Crossref Google Scholar
[101]
Ratti, A., Gumina, V., Lenzi, P., Bossolasco, P., Fulceri, F., Volpe, C., Bardelli, D., Pregnolato, F., Maraschi, A., Fornai, F. et al. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Neurobiology of Disease, 2020, 145: 105051.
Crossref Google Scholar
[102]
Rodriguez-Ortiz, C. J., Flores, J. C., Valenzuela, J. A., Rodriguez, G. J., Zumkehr, J., Tran, D. N., Kimonis, V. E., Kitazawa, M. The myoblast C2C12 transfected with mutant valosin-containing protein exhibits delayed stress granule resolution on oxidative stress. Am J Pathol, 2016, 186(6): 1623–1634.
Crossref Google Scholar
[103]
Mediani, L., Antoniani, F., Galli, V., Vinet, J., Carrà, A. D., Bigi, I., Tripathy, V., Tiago, T., Cimino, M., Leo, G. et al. Hsp90-mediated regulation of DYRK3 couples stress granule disassembly and growth via mTORC1 signaling. EMBO Reports, 2021, 22(5): e51740.
Crossref Google Scholar
[104]
Guo, L., Kim, H. J., Wang, H. J., Monaghan, J., Freyermuth, F., Sung, J. C., O’Donovan, K., Fare, C. M., Diaz, Z., Singh, N. et al. Nuclear-import receptors reverse aberrant phase transitions of RNA-binding proteins with prion-like domains. Cell, 2018, 173(3): 677–692.e20.
Crossref Google Scholar
[105]
Brown, D. G., Shorter, J., Wobst, H. J. Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia. Bioorganic & Medicinal Chemistry Letters, 2020, 30(4): 126942.
Crossref Google Scholar
[106]
Chitiprolu, M., Jagow, C., Tremblay, V., Bondy-Chorney, E., Paris, G., Savard, A., Palidwor, G., Barry, F. A., Zinman, L., Keith, J. et al. A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy. Nat Commu, 2018, 9: 2794.
Crossref Google Scholar
[107]
Asadi, M. R., Sadat Moslehian, M., Sabaie, H., Jalaiei, A., Ghafouri-Fard, S., Taheri, M., Rezazadeh, M. Stress Granules and neurodegenerative disorders: A scoping review. Frontiers in Aging Neuroscience, 2021, 13: 650740.
Crossref Google Scholar
[108]
Zhang, X., Wang, F. C., Hu, Y., Chen, R. Z., Meng, D. W., Guo, L., Lv, H. L., Guan, J. S., Jia, Y. C. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. Brain, 2020, 143(5): 1350–1367.
Crossref Google Scholar
[109]
Ratti, A., Buratti, E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. Journal of Neurochemistry, 2016, 138(Suppl 1): 95–111.
Crossref Google Scholar
[110]
Liao, Y. Z., Ma, J., Dou, J. Z. The role of TDP-43 in neurodegenerative disease. Molecular Neurobiology, 2022, 59(7): 4223–4241.
Crossref Google Scholar
[111]
Tziortzouda, P., Van Den Bosch, L., Hirth, F. Triad of TDP43 control in neurodegeneration: Autoregulation, localization and aggregation. Nat Rev Neurosci, 2021, 22(4): 197–208.
Crossref Google Scholar
[112]
Portz, B., Lee, B. L., Shorter, J. FUS and TDP-43 phases in health and disease. Trends in Biochemical Sciences, 2021, 46(7): 550–563.
Crossref Google Scholar
[113]
Huang, C. H., Yan, S., Zhang, Z. J. Maintaining the balance of TDP-43, mitochondria, and autophagy: A promising therapeutic strategy for neurodegenerative diseases. Translational Neurodegeneration, 2020, 9(1): 40.
Crossref Google Scholar
[114]
de Boer, E. M. J., Orie, V. K., Williams, T., Baker, M. R., De Oliveira, H. M., Polvikoski, T., Silsby, M., Menon, P., van den Bos, M., Halliday, G. M. et al. TDP-43 proteinopathies: A new wave of neurodegenerative diseases. J Neurol, Neurosurgery & Psychiatry, 2021, 92(1): 86–95.
Crossref Google Scholar
[115]
Layalle, S., They, L., Ourghani, S., Raoul, C., Soustelle, L. Amyotrophic lateral sclerosis genes in drosophila melanogaster. Int J Mol Sci, 2021, 22(2): 904.
Crossref Google Scholar
[116]
Zuo, X. X., Zhou, J., Li, Y. M., Wu, K., Chen, Z. G., Luo, Z. W., Zhang, X. R., Liang, Y., Esteban, M. A., Zhou, Y. et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nature Structural & Molecular Biology, 2021, 28(2): 132–142.
Crossref Google Scholar
[117]
Gasset-Rosa, F., Lu, S., Yu, H. Y., Chen, C., Melamed, Z., Guo, L., Shorter, J., da Cruz, S., Cleveland, D. W. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron, 2019, 102(2): 339–357.e7.
Crossref Google Scholar
[118]
Miguel, L., Frébourg, T., Campion, D., Lecourtois, M. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiology of Disease, 2011, 41(2): 398–406.
Crossref Google Scholar
[119]
McAlary, L., Chew, Y. L., Lum, J. S., Geraghty, N. J., Yerbury, J. J., Cashman, N. R. Amyotrophic lateral sclerosis: Proteins, proteostasis, prions, and promises. Frontiers in Cellular Neuroscience, 2020, 14: 581907.
Crossref Google Scholar
[120]
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., Ke, Y. D. TDP-43 and inflammation: Implications for amyotrophic lateral sclerosis and frontotemporal dementia. Int J Mol Sci, 2021, 22(15): 7781.
Crossref Google Scholar
[121]
Correia, A. S., Patel, P., Dutta, K., Julien, J. P. Inflammation induces TDP-43 mislocalization and aggregation. PLoS One, 2015, 10(10): e0140248.
Crossref Google Scholar
[122]
Lin, M. T., Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006, 443(7113): 787–795.
Crossref Google Scholar
[123]
Mao, H. Y., Fang, X., Floyd, K. M., Polcz, J. E., Zhang, P., Liu, B. Induction of microglial reactive oxygen species production by the organochlorinated pesticide dieldrin. Brain Research, 2007, 1186: 267–274.
Crossref Google Scholar
[124]
Baltazar, M. T., Dinis-Oliveira, R. J., de Lourdes Bastos, M., Tsatsakis, A. M., Duarte, J. A., Carvalho, F. Pesticides exposure as etiological factors of Parkinson’s disease and other neurodegenerative diseases—a mechanistic approach. Toxicology Letters, 2014, 230(2): 85–103.
Crossref Google Scholar
[125]
Andrew, Churg,. Interactions of exogenous or evoked agents and particles: The role of reactive oxygen species. Free Radical Biology and Medicine, 2003, 34(10): 1230–1235.
Crossref Google Scholar
[126]
Barber, S. C., Shaw, P. J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radical Biology and Medicine, 2010, 48(5): 629–641.
Crossref Google Scholar
[127]
Iguchi, Y., Katsuno, M., Takagi, S., Ishigaki, S., Niwa, J. I., Hasegawa, M., Tanaka, F., Sobue, G. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. Neurobiology of Disease, 2012, 45(3): 862–870.
Crossref Google Scholar
[128]
Annesley, S. J., Fisher, P. R. Mitochondria in health and disease. Cells, 2019, 8(7): 680.
Crossref Google Scholar
[129]
Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S. et al. Oxidative stress in human pathology and aging: Molecular mechanisms and perspectives. Cells, 2022, 11(3): 552.
Crossref Google Scholar
[130]
Bellezza, I., Giambanco, I., Minelli, A., Donato, R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2018, 1865(5): 721–733.
Crossref Google Scholar
[131]
Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., Biswal, S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research, 2002, 62(18): 5196–5203.
Google Scholar
[132]
Pehar, M., Vargas, M. R., Cassina, P., Barbeito, A. G., Beckman, J. S., Barbeito, L. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegenerative Diseases, 2005, 2(3–4): 139–146.
Crossref Google Scholar
[133]
Kodavati, M., Wang, H. B., Hegde, M. L. Altered mitochondrial dynamics in motor neuron disease: An emerging perspective. Cells, 2020, 9(4): 1065.
Crossref Google Scholar
[134]
Takuma, K., Yan, S. S., Stern, D. M., Yamada, K. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in alzheimer’s disease. J Pharmacol Sci, 2005, 97(3): 312–316.
Crossref Google Scholar
[135]
Bano, D., Nicotera, P. Ca2+ signals and neuronal death in brain ischemia. Stroke, 2007, 38(2): 674–676.
Crossref Google Scholar
[136]
Hoyles, L., Snelling, T., Umlai, U. K., Nicholson, J. K., Carding, S. R., Glen, R. C., McArthur, S. Microbiome-host systems interactions: Protective effects of propionate upon the blood-brain barrier. Microbiome, 2018, 6(1): 55.
Crossref Google Scholar
[137]
Wright, M. L., Fournier, C., Houser, M. C., Tansey, M., Glass, J., Hertzberg, V. S. Potential role of the gut microbiome in ALS: A systematic review. Biol Res Nurs, 2018, 20(5): 513–521.
Crossref Google Scholar
[138]
Foster, J. A., McVey Neufeld, K. A. Gut–brain axis: How the microbiome influences anxiety and depression. Trends in Neurosciences, 2013, 36(5): 305–312.
Crossref Google Scholar
[139]
Wu, S. P., Yi, J. X., Zhang, Y. G., Zhou, J. S., Sun, J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiological Reports, 2015, 3(4): e12356.
Crossref Google Scholar
[140]
Zhang, Y. G., Wu, S. P., Yi, J. X., Xia, Y. L., Jin, D. P., Zhou, J. S., Sun, J. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clinical Therapeutics, 2017, 39(2): 322–336.
Crossref Google Scholar
[141]
Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Kleimeyer, C., Moresi, C., Harnik, Y., Zur, M. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature, 2019, 572(7770): 474–480.
Crossref Google Scholar
[142]
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., Cryan, J. F. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry, 2013, 18(6): 666–673.
Crossref Google Scholar
[143]
Bartanusz, V., Jezova, D., Alajajian, B., Digicaylioglu, M. The blood–spinal cord barrier: Morphology and Clinical Implications. Annals of Neurology, 2011, 70(2): 194–206.
Crossref Google Scholar
[144]
Kakaroubas, N., Brennan, S., Keon, M., Saksena, N. K. Pathomechanisms of blood-brain barrier disruption in ALS. Neuroscience Journal, 2019, 2019: 2537698.
Crossref Google Scholar
[145]
Chen, X. S., Gawryluk, J. W., Wagener, J. F., Ghribi, O., Geiger, J. D. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer’s disease. J Neuroinflammation, 2008, 5: 12.
Crossref Google Scholar
[146]
Bouchat, J., Couturier, B., Marneffe, C., Gankam-Kengne, F., Balau, B., De Swert, K., Brion, J. P., Poncelet, L., Gilloteaux, J., Nicaise, C. Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood–brain barrier disruption in a murine model of osmotic demyelination syndrome. Glia, 2018, 66(3): 606–622.
Crossref Google Scholar
[147]
Obermeier, B., Daneman, R., Ransohoff, R. M. Development, maintenance and disruption of the blood-brain barrier. Nat Med, 2013, 19(12): 1584–1596.
Crossref Google Scholar
[148]
Lee, S., Kang, B. M., Kim, J. H., Min, J., Kim, H. S., Ryu, H., Park, H., Bae, S., Oh, D., Choi, M. et al. Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood-brain barrier permeability in chronically stressed mice. Sci Rep, 2018, 8: 13064.
Crossref Google Scholar
[149]
Sántha, P., Veszelka, S., Hoyk, Z., Mészáros, M., Walter, F. R., Tóth, A. E., Kiss, L., Kincses, A., Oláh, Z., Seprényi, G. et al. Restraint stress-induced morphological changes at the blood-brain barrier in adult rats. Frontiers in Molecular Neuroscience, 2016, 8: 88.
Crossref Google Scholar
[150]
Menard, C., Pfau, M. L., Hodes, G. E., Kana, V., Wang, V. X., Bouchard, S., Takahashi, A., Flanigan, M. E., Aleyasin, H., LeClair, K. B. et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci, 2017, 20(12): 1752–1760.
Crossref Google Scholar
[151]
Van den Broeck, K., Pieters, G., Claes, L., Berens, A., Raes, F. Overgeneral autobiographical memory predicts higher prospective levels of depressive symptoms and intrusions in borderline patients. Memory, 2016, 24(10): 1302–1310.
Crossref Google Scholar
[152]
Waters, S., Swanson, M. E. V., Dieriks, B. V., Zhang, Y. B., Grimsey, N. L., Murray, H. C., Turner, C., Waldvogel, H. J., Faull, R. L. M., An, J. Y. et al. Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS. Acta Neuropathologica Communications, 2021, 9(1): 1–17.
Crossref Google Scholar
[153]
Regan, R. F., Guo, Y. P. Toxic effect of hemoglobin on spinal cord neurons in culture. J Neurotrauma, 1998, 15(8): 645–653.
Crossref Google Scholar
[154]
Witzel, S., Maier, A., Steinbach, R., Grosskreutz, J., Koch, J. C., Sarikidi, A., Petri, S., Günther, R., Wolf, J., Hermann, A. et al. Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis. JAMA Neurology, 2022, 79(2): 121–130.
Crossref Google Scholar
Stress and Brain
Volume 3 Issue 4,
December 2023
Pages 159-178
DOI: 10.26599/SAB.2023.9060002
Cite this article:
Lu C, Xu X. The Role of Stress in the Progression of Motor Neuron Disease: Mechanisms and Implications for Treatment. Stress and Brain, 2023, 3(4): 159-178. https://doi.org/10.26599/SAB.2023.9060002

1958

Views

857

Downloads

0

Crossref

Altmetrics
Received: 27 December 2022
Revised: 23 October 2023
Accepted: 26 October 2023
Published: 05 December 2023
© The Author(s) 2023

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attributtion-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission.
Return